NVOS News and Press, Novo Integrated Sciences Inc. From 02/20/24

The Waiver Exempts any determination of non-compliance associated to Nasdaq’s Minimum Bid Price Requirement Rule Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announces today the Company has received a Limited Waiver, specific...

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announces today Mr. Robert Oliva has been appointed as the Company’s new President. Mr. Oliva succeeds Mr. Christopher David, who remains as the Company’s Chief Operating Officer and ...

Novo Integrated Sciences Inc. (NVOS) is expected to report for quarter end 2023-11-30

2024-01-22 16:49:25 ET More on Novo Integrated Sciences Novo Integrated Sciences regains compliance with Nasdaq minimum bid price requirement Novo Integrated Sciences stock plunges 54% amid stock split, debt update Financial information for Novo Integrated Sciences ...

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation...

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announces today Blacksheep Trust (“Blacksheep”), a New York-based private express trust settled for the purposes of Benevolent Services with (i) a 33% allocation to charitable service...

2023-12-14 17:07:13 ET More on Novo Integrated Sciences Novo Integrated Sciences regains compliance with Nasdaq minimum bid price requirement Novo Integrated Sciences stock plunges 54% amid stock split, debt update Financial information for Novo Integrated Sciences ...

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints providing services and product inno...

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) proudly announces the signing of a Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India (“PCHPL”). This partnership initiates a strategic initiative to introduce new ...

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) today announced the United States District Court for the Central District of California has approved the Purchase and Sale Agreement (“PSA”) which provides for the Company to acquire ...